Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs RxION Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and RxION Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 478 · Grade C

RxION Health

Visit RxION Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 52 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make RxION Health a bad call — it's best for readers comparing supply lengths who can verify the current price and renewal. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
77
Transparency
90
20
Access Breadth
93
30
Clinical Oversight
92
81
Track Record
88
78
CoreAge RxBrief Score 94 · 52RxION Health

Price, coverage & the tracker

CoreAge RxRxION Health
Brief Score94/100 (A)52/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199 listed for a one-month supply of compounded semaglutide.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$299 advertised for a one-month supply of compounded tirzepatide. Confirm the next charge.

CoverageUS only; restrictions by state, confirmed at intakeAvailability depends on state and treatment. Some patients need a video consultation.
Brand-name accessNot confirmedRxION lists Wegovy and Zepbound separately.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

RxION Health: Check the selected price and when the refill goes for review.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.